Investors Who Lost Money With Shares of Ardelyx, Inc. (NASDAQ: ARDX) Should Contact the Shareholders Foundation in Connection With Lawsuit
SAN DIEGO, CA, August 26, 2024 (Newswire.com) - A lawsuit was filed for certain investors in shares of Ardelyx, Inc. (NASDAQ:ARDX). Investors in NASDAQ: ARDX shares should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The Shareholders Foundation, Inc. announced that a lawsuit was filed for certain investors in shares of Ardelyx, Inc. (NASDAQ:ARDX).
Investors that purchased shares of Ardelyx, Inc. (NASDAQ: ARDX) have certain options and for certain investors there are short and strict deadlines running. NASDAQ: ARDX investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
On August 16, 2024, a lawsuit was filed by an investor in NASDAQ: ARDX shares against Ardelyx, Inc. over alleged securities laws violations. The plaintiff alleged that as a result of Defendants' wrongful acts and omissions, and the precipitous decline in the market value of the Company's securities, investors who purchased shares of of Ardelyx, Inc. (NASDAQ: ARDX) between October 31, 2023 and July 1, 2024 have suffered significant losses and damages.
The plaintiff says that in the 10-Q Forms filed by Ardelyx, Inc on October 31, 2023, and May 2, 2024 with the SEC , and in its Form 10-K filed on February 22, 2024, Ardelyx, Inc indicated that it would apply to include XPHOZAH in the ESRD PPS Transitional Drug Add-on Payment Adjustment ("TDAPA") program. Further, in an earnings call on May 2, 2024, a Defendant advised analysts that "our intent is to enter TDAPA."
However, then on July 2, 2024, Ardelyx, Inc. disclosed that it had decided not to apply to include XPHOZAH in TDAPA. Shares of Ardelyx, Inc. (NASDAQ: ARDX) declined to as low as $5.07 per share on July 02, 2024.
Those who purchased Ardelyx, Inc. (NASDAQ: ARDX) shares should contact the Shareholders Foundation, Inc.
CONTACT:
Shareholders Foundation, Inc.
Michael Daniels
+1 (858) 779-1554
mail@shareholdersfoundation.com
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
The Shareholders Foundation, Inc. is a professional portfolio legal monitoring and a settlement claim filing service, which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. The Shareholders Foundation, Inc. is not a law firm. Any referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is only provided as a public service. It is not intended as legal advice and should not be relied upon.
Contact Information
Michael Daniels
Manager
mail@shareholdersfoundation.com
858-779-1554
SOURCE: Shareholders Foundation, Inc.
Source: Shareholders Foundation, Inc.
Related Media
